Home  Clinical trials Products in Development AZD0530
|
|
A number of clinical trials with AZD0530 Ongoing studies are currently in progress.
More studies will be added in due course. Additional AZD0530 Ongoing study information is available on ClinicalTrials.gov. | Study Number | Study Phase | Start Date | Recruitment Status | | D8180C00015 | Phase II | 18 Feb 2008 | Not yet Recruiting | | A Phase II, Double-Blind, Placebo-Controlled, Multi-Centre, Randomised Study of AZD0530 in Patients With Advanced Ovarian Cancer Sensitive to Platinum-Based Chemotherapy | | D8180C00021 | Phase I | 6 Jun 2008 | Recruiting | | A Phase I, Open-label, Dose-escalation Study to Assess the Safety and Tolerability of AZD0530 in Patients with Advanced Solid Malignancies | | D8180C00023 | Phase I | 15 Mar 2007 | Recruiting | | A Phase I, Open-label Study to assess the safety and tolerability of AZD0530 in combination with Carboplatin and/or Paclitaxel chemotherapy in patients with solid tumours. | | D8180C00034 | Phase II | 24 Jan 2008 | Recruiting | | A Phase II, Randomised, Open-Label, Pilot Study to Evaluate the Safety and Effects on Bone Resorption of AZD0530 in Patients with Prostate Cancer or Breast Cancer with Metastatic Bone Disease. |
|
|
|
|